CN121464128A - 吡啶氮氧化合物与富马酸的共晶体及其组合物、用途和制备方法 - Google Patents

吡啶氮氧化合物与富马酸的共晶体及其组合物、用途和制备方法

Info

Publication number
CN121464128A
CN121464128A CN202480039719.8A CN202480039719A CN121464128A CN 121464128 A CN121464128 A CN 121464128A CN 202480039719 A CN202480039719 A CN 202480039719A CN 121464128 A CN121464128 A CN 121464128A
Authority
CN
China
Prior art keywords
crystal
fumaric acid
ray powder
powder diffraction
diffraction pattern
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480039719.8A
Other languages
English (en)
Chinese (zh)
Inventor
张勇
程宏明
王明力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiyu Pharmaceutical Technology Co ltd
Original Assignee
Shanghai Jiyu Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiyu Pharmaceutical Technology Co ltd filed Critical Shanghai Jiyu Pharmaceutical Technology Co ltd
Publication of CN121464128A publication Critical patent/CN121464128A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN202480039719.8A 2023-06-14 2024-06-14 吡啶氮氧化合物与富马酸的共晶体及其组合物、用途和制备方法 Pending CN121464128A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN2023107051751 2023-06-14
CN202310705175 2023-06-14
CN2024107508051 2024-06-11
CN202410750805 2024-06-11
PCT/CN2024/099157 WO2024255833A1 (fr) 2023-06-14 2024-06-14 Co-cristal d'oxynitrure de pyridine et d'acide fumarique, composition le comprenant, utilisation et procédé de préparation associés

Publications (1)

Publication Number Publication Date
CN121464128A true CN121464128A (zh) 2026-02-03

Family

ID=93851340

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480039719.8A Pending CN121464128A (zh) 2023-06-14 2024-06-14 吡啶氮氧化合物与富马酸的共晶体及其组合物、用途和制备方法

Country Status (3)

Country Link
CN (1) CN121464128A (fr)
TW (1) TW202500551A (fr)
WO (1) WO2024255833A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI770607B (zh) * 2019-09-12 2022-07-11 大陸商上海濟煜醫藥科技有限公司 吡啶氮氧化合物及其製備方法和用途
JP2024509939A (ja) * 2021-03-11 2024-03-05 シャンハイ ジェミンケア ファーマシューティカル カンパニー，リミティド ピリジン窒素酸化物の結晶形態およびその使用

Also Published As

Publication number Publication date
WO2024255833A1 (fr) 2024-12-19
TW202500551A (zh) 2025-01-01

Similar Documents

Publication Publication Date Title
JP5567610B2 (ja) 臭化チオトロピウムの新規な形態およびそれを製造する方法
AU2017373239B2 (en) Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereof
JP2007302658A (ja) イマチニブメシレートの多形フォーム及び新規結晶フォーム及び非晶フォーム並びにフォームαの調製方法
CN102985423A (zh) 嘌呤衍生物的结晶形式
CN121471151A (zh) Btk抑制剂的晶型
CN112142679A (zh) 一种吉非替尼与香草酸共晶甲醇溶剂合物及其制备方法
CN111574359A (zh) 乐伐替尼-没食子酸共晶晶型及其应用
WO2015176677A1 (fr) Formes cristallines et amorphisme de composé d'oxazolidinone
CN116262746A (zh) 阿伐曲泊帕的马来酸盐新晶型及其制备方法
CN117327066A (zh) 一种新多晶型、其制备方法及其用于制备药物的用途
EP4570802A1 (fr) Forme de sel et forme cristalline d'un composé cyclique fusionné de benzazépine et leur utilisation
CN111484489B (zh) 无定形的b-raf激酶二聚体抑制剂
WO2024255833A1 (fr) Co-cristal d'oxynitrure de pyridine et d'acide fumarique, composition le comprenant, utilisation et procédé de préparation associés
WO2019052470A1 (fr) Forme cristalline d'eldecalcitol, composition pharmaceutique et procédé de préparation et utilisation
CN116262748A (zh) 维利西呱的新晶型及其制备方法
EP4450488A1 (fr) Forme cristalline d'un dérivé de cycle aromatique, son procédé de préparation et son application
CN115650917B (zh) 草乌甲素多晶型及其制备方法和应用
CN105859748B (zh) 多环化合物钠盐及其多晶型、制备方法及应用
CN118724874A (zh) 莫博替尼的对羟基苯甲酸共晶及其制备方法和应用
CN118724896A (zh) 阿达格拉西布的烟酰胺共晶及其制备方法和应用
CN121419965A (zh) 吡啶氮氧化合物的盐型、共晶及其制备方法和应用
CN115872938A (zh) 二氨基嘧啶类化合物的柠檬酸盐新晶型及其制备方法
WO2018001335A1 (fr) Formes cristallines de nbi-98854, procédé de préparation s'y rapportant et utilisation associée
TW202506661A (zh) 一種酪氨酸激酶抑制劑的可藥用鹽、結晶形式及其製備方法
WO2026026769A1 (fr) Forme cristalline d'un composé isoindoline fluoro-substitué, son procédé de préparation et son utilisation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination